<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36964995</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2362</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of clinical investigation</Title><ISOAbbreviation>Eur J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>The definition of long COVID used in interventional studies.</ArticleTitle><Pagination><StartPage>e13989</StartPage><MedlinePgn>e13989</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eci.13989</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">There has been little consensus for a specific definition of long COVID, though several organizations have created varying ones. We sought to examine the definition of long COVID used in ongoing clinical trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched 'long COVID' and related terms on both PubMed and clinicaltrials.gov for randomized studies that either included patients with long COVID or had a persistent or long-term COVID-related outcome and abstracted long COVID definition components.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 92 studies, a laboratory-only confirmed diagnosis of COVID-19 was stipulated in 54.3% (n&#x2009;=&#x2009;50) studies. We found eight different time durations specified for how long symptoms needed to have occurred, ranging from 4 to 52&#x2009;weeks, with 12&#x2009;weeks being the most common (34.8%; n&#x2009;=&#x2009;32). 35.9% (n&#x2009;=&#x2009;33) did not specify a time duration. There were 57 different symptoms specified in total, with a median of one symptom identified per study (range 0-32). 8.7% of trials adhered to NICE or WHO definitions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Standardized definitions of long COVID should be applied in studies assessing this condition to unify and harmonize research on this topic.</AbstractText><CopyrightInformation>&#xa9; 2023 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haslam</LastName><ForeName>Alyson</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7876-3978</Identifier><AffiliationInfo><Affiliation>University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivier</LastName><ForeName>Timoth&#xe9;e</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6936-5783</Identifier><AffiliationInfo><Affiliation>University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, Geneva University Hospital, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Vinay</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-6110-8221</Identifier><AffiliationInfo><Affiliation>University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Clin Invest</MedlineTA><NlmUniqueID>0245331</NlmUniqueID><ISSNLinking>0014-2972</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID long-haulers</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent COVID</Keyword><Keyword MajorTopicYN="N">randomized studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>15</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36964995</ArticleId><ArticleId IdType="doi">10.1111/eci.13989</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Yong E. Long-haulers are fighting for their future. The Atlantic. Accessed September 6, 2022. https://www.theatlantic.com/science/archive/2021/09/covid-19-long-haulers-pandemic-future/619941/</Citation></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (NICE); 2020.</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Accessed September 5, 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference><Reference><Citation>Munblit D, O'Hara ME, Akrami A, Perego E, Olliaro P, Needham DM. Long COVID: aiming for a consensus. Lancet Respir Med. 2022;10(7):632-634. doi:10.1016/S2213-2600(22)00135-7</Citation></Reference><Reference><Citation>Wisk LE, Nichol G, Elmore JG. Toward unbiased evaluation of Postacute sequelae of SARS-CoV-2 infection: challenges and solutions for the long haul ahead. Ann Intern Med. 2022;175(5):740-743. doi:10.7326/M21-4664</Citation></Reference><Reference><Citation>Committee W, Gluckman TJ, Bhave NM, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution set Oversight Committee. J Am Coll Cardiol. 2022;79(17):1717-1756. doi:10.1016/j.jacc.2022.02.003</Citation></Reference><Reference><Citation>Ceban F, Leber A, Jawad MY, et al. Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. Infect Dis (Lond). 2022;54(7):467-477. doi:10.1080/23744235.2022.2043560</Citation></Reference><Reference><Citation>Cutler DM. The economic cost of long COVID: an update. 2022. Accessed March 27, 2023. https://scholar.harvard.edu/files/cutler/files/long_covid_update_7-22.pdf</Citation></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID conditions among adult COVID-19 survivors aged 18-64 and &#x2265;65&#x2009;years-United States, march 2020-November 2021. MMWR Morb Mortal Wkly Rep. 2022;71(21):713-717. doi:10.15585/mmwr.mm7121e1</Citation></Reference><Reference><Citation>Mazer B. Long COVID could Be a &#x2018;mass deterioration event.&#x2019; The Atlantic. 2022. Accessed January 11, 2023. https://www.theatlantic.com/health/archive/2022/06/long-covid-chronic-illness-disability/661285/?utm_source=twitter&amp;utm_medium=social&amp;utm_campaign=share</Citation></Reference><Reference><Citation>Wisk LE, Gottlieb MA, Spatz ES, et al. Association of Initial SARS-CoV-2 test positivity with patient-reported well-being 3 months after a symptomatic illness. JAMA Netw Open. 2022;5(12):e2244486. doi:10.1001/jamanetworkopen.2022.44486</Citation></Reference><Reference><Citation>Jaffri A, Jaffri UA. Post-intensive care syndrome and COVID-19: crisis after a crisis? Heart Lung. 2020;49(6):883-884. doi:10.1016/j.hrtlng.2020.06.006</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>